Trials / Conditions / Metastatic Intraocular Melanoma
Metastatic Intraocular Melanoma
6 registered clinical trials studyying Metastatic Intraocular Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases NCT01730157 | Case Comprehensive Cancer Center | EARLY_Phase 1 |
| Terminated | Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery NCT01533948 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye NCT01413191 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye NCT00329641 | National Cancer Institute (NCI) | Phase 2 |
| Completed | VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery NCT00450255 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma NCT00085189 | University of Southern California | Phase 2 |